The epilepsy medication valproate is responsible for "severe malformations" in 2,150 to 4,100 children in France since the drug was first marketed in the country in 1967, according to a preliminary study by French health authorities.
Women who took the drug during pregnancy to treat epilepsy were four times more likely to give birth to babies with congenital malformations, said the report, jointly issued by the French National Agency for the Safety of Medicines (ANSM) and the national health insurance administration.
"The study confirms the highly teratogenic" -- that is, capable of causing birth defects --- "nature of valproate," Mahmoud Zureik, scientific director of ANSM and co-author of the report, told AFP ahead of its release.
GMT 14:12 2018 Tuesday ,23 January
Oscar best director nomineesGMT 14:09 2018 Tuesday ,23 January
Oscar best actress nomineesGMT 14:06 2018 Tuesday ,23 January
Oscar best actor nomineesGMT 13:58 2018 Tuesday ,23 January
Oscar best foreign film nomineesGMT 20:03 2018 Monday ,22 January
Eurozone approves 6.7-bln-euro bailout tranche for GreeceGMT 20:00 2018 Monday ,22 January
Trump to travel to Davos as shutdown deal reached: W.HouseGMT 19:57 2018 Monday ,22 January
Democrats to vote to reopen US government: SchumerGMT 19:53 2018 Monday ,22 January
Afrin clashes kill 54 Syrian Kurd and pro-Turkey fighters: monitorMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor